Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ciprofloxacin (liposomal)

EU orphan designation number: EU/3/09/652   
Active ingredient: Ciprofloxacin (liposomal)
Indication: Treatment of cystic fibrosis
Sponsor: Aradigm Limited
90 Fetter Lane, London EC4A 1EQ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/07/2009 Orphan designation EMEA/OD/037/09 (2009)6037 of 24/07/2009
13/11/2015 Transfer of orphan designation EMA/OD/037/09/T/01 (2015)8034 of 11/11/2015